1 / 17

A Look at Osteoporosis Screening Guidelines

A Look at Osteoporosis Screening Guidelines. Cynthia Phelan PGY 1 2003 08 07. Osteoporosis. Systemic disease Low bone mass Micro-architectural deterioration of bone tissue Increased fragility Increase risk of fracture WHO – T-score lower than -2.5. Societal Impact. 1 in 4 women

werner
Download Presentation

A Look at Osteoporosis Screening Guidelines

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. A Look at Osteoporosis Screening Guidelines Cynthia Phelan PGY 1 2003 08 07

  2. Osteoporosis • Systemic disease • Low bone mass • Micro-architectural deterioration of bone tissue • Increased fragility • Increase risk of fracture • WHO – T-score lower than -2.5

  3. Societal Impact • 1 in 4 women • 1 in 8 men • Cause of over 70% of fractures in people over the age of 45 • High cost to society for treatment of fractures and associated morbidity

  4. Important for all patients! • Prevention efforts must begin early • Peak bone mass attained by the third decade • Encourage exercise – resistance and impact • Nutrition important • Encourage Ca (1000 -1500mg) and Vit D (400 - 800 IU) supplementation in those who have poor dietary intake

  5. Who to screen? • Screen all who have one of … • Age >65yrs • History of fragility fracture after age 40 • Osteoporosis in a first degree relative • Thin build….BMI < 20 or wt < 57.8Kg • Early menopause (<45yrs) • Chronic hypogonadism • Chronic malnutrition / malabsorption • Chemotherapy (if long term survival expected)

  6. Who to screen? • Screen all who have one of … • Glucocorticoid therapy • 7.5mg of prednisone per day for more than 3 months • Cushing's Syndrome • Prolonged use of anticonvulsants (>10yrs) • Documented loss of height • Development of kyphosis after menopause • Primary hyperparathyroidism

  7. Who to screen?? • Screen patients who have two or more of.. • Current smoking • History of hyperthyroidism • Low calcium intake • Alcoholism • Excessive caffeine intake

  8. Who to screen?? • 4 Key Risk Factors have been found to be most predictive of potential fracture related to osteoporosis • Low Bone Mineral Density • Prior Fragility Fracture • Age >65 • Family History of Osteoporosis

  9. Screening Tools • DEXA (Dual energy X-ray absorptiometry) • Single most predictive test for identification of patients at risk • Gold standard • Useful for assessing patient current BMD as compared to standard and for watching changes in pts BMD over time • Operator error may alter results • Results may also be skewed by compression fractures

  10. Screening Tools • Peripheral Bone Density Testing • Measured by DEXA or US at several sites (radius, phalanx, calcaneus) • Used more often in under serviced areas • Useful for predicting fracture risk • Not good for following pts thus not a recommended screening tool to date

  11. Screening Tools • Blood and Urine Studies of bone turnover markers (CBC, Ca, Alk Phos, Creat) • Useful to investigate secondary causes • Individual patients show large variation in test results from one day to the next • Cannot readily be used to identify patients at risk • Not recommended as screening tools or as tools to monitor effect of therapy

  12. Diagnosis • Recommendations • Patients at increased risk and those over age 65 should have BMD done via DEXA • Peripheral US or DEXA should not be used for following patients • Additional studies are required before biochemical markers become a useful tool in screening and surveillance of osteoporosis

  13. Interpretation of Results

  14. When to start treatment • Therapy used to prevent bone deterioration and reduce fractures • Treating women with T-score less -2 or a T-score less than -1.5 with risk factors has been deemed cost effective. • Clinical decision making must be made on a patient to patient basis.

  15. Take Home Points • Consider risk factors in all patients • Screen patients who are at risk with DEXA • Don’t neglect elderly patients with multiple medical problems – they may benefit greatly from therapy (even if they are resistant to additional medications) • Consider Rx in all patients with t-score less than -1.5 (+risk factors) or -2.

  16. Take Home Points • Prevention, prevention, prevention Start very early! • Yuen CK et al. Canadian Consensus on Menopause and Osteoporosis. Osteoporosis. Journal of Obstetrics and Gynecology of Canada. 2002; 24(10): 35-44. • Brown JP et al. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002; 167(10): S1-36.

More Related